Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Indirect | |
Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Performance Restricted Stock Units | 0 | Oct 6, 2023 | Direct | ||
Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Restricted Stock Units | 0 | Oct 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HZNP | Horizon Therapeutics Public Ltd Co | Oct 6, 2023 | 7 | -$979K | 4 | Oct 6, 2023 | EVP, General Counsel |
HZNP | Horizon Therapeutics Public Ltd Co | Mar 1, 2023 | 3 | -$776K | 4 | Mar 6, 2023 | EVP, General Counsel |
HZNP | Horizon Therapeutics Public Ltd Co | Jan 4, 2023 | 1 | $0 | 4 | Jan 6, 2023 | EVP, General Counsel |
HZNP | Horizon Therapeutics Public Ltd Co | Aug 4, 2022 | 1 | $49.7K | 4 | Aug 8, 2022 | EVP, General Counsel |
HZNP | Horizon Therapeutics Public Ltd Co | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | EVP, General Counsel |
HZNP | Horizon Therapeutics Public Ltd Co | Mar 1, 2022 | 0 | $0 | 3 | Mar 2, 2022 | EVP, General Counsel |